2026 Global: Nonvascular Interventional Radiology Device Market -Competitive Review (2032) report
Description
The 2026 Global: Nonvascular Interventional Radiology Device Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Key players defining the nonvascular interventional radiology device market include Medtronic (Dublin, Ireland), Boston Scientific (Marlborough, United States), Terumo (Tokyo, Japan), Cook Medical (Bloomington, United States), Merit Medical Systems (South Jordan, United States), AngioDynamics (Latham, United States), Stryker (Kalamazoo, United States), Becton, Dickinson and Company (Franklin Lakes, United States), Philips (Amsterdam, Netherlands), and Guerbet (Villepinte, France). These firms collectively provide nonvascular IR devices such as biopsy needles, ablation technologies, embolic materials, drainage and access tools, as well as image-guidance platforms. Medtronic and Boston Scientific maintain broad portfolios spanning embolization and tumor ablation technologies, while Terumo furnishes extensive microcatheters, guidewires, and coils widely used in percutaneous procedures. Cook Medical and Merit Medical emphasize needle-based and catheter-based systems for biopsy, drainage, and embolization, with Merit’s embolic microspheres representing a benchmark product. AngioDynamics complements this mix with ablation platforms, angiographic accessories, and embolic products; Stryker contributes neurovascular coils, access sheaths, and ancillary IR instruments; BD supplies safety needles and biopsy devices.
Across these firms, core product families span biopsy needles and guidewires, ablation catheters, embolic beads and liquids, drainage and access systems, and advanced imaging platforms for fluoroscopy, CT, and ultrasound guidance. Medtronic's IR portfolio emphasizes embolization and energy-based therapies, supported by globally deployed support networks. Boston Scientific markets a broad line of interventional tools including diagnostic and therapeutic catheters, with a strong presence in percutaneous tumor ablation workflows. Terumo's catalog features microcatheters, hydrophilic guidewires, protective devices, coils used in liver, renal, and pulmonary interventions. Cook Medical and Merit Medical lead in needle and access systems and in embolic materials; Merit's embolic microspheres are widely used in transarterial embolization. AngioDynamics offers ablative platforms and embolic products, while Stryker provides neurovascular and peripheral IR coils and accessories. BD's needle and biopsy devices complement radiology workflows, Philips advances interventional imaging suites and workstations, and Guerbet supplies iodinated contrast agents vital for image-guided procedures.
Overall, the nonvascular IR device market is characterized by diversified portfolios, regional manufacturing hubs, and increasing adoption of image-guided percutaneous therapies. These ten companies maintain global footprints across North America, Europe, and Asia, leveraging partnerships with hospitals, clinics, and research centers to drive clinical adoption and procedural efficiency. Consolidation and strategic collaborations continue to shape product development in needle-based systems, energy-based ablation, embolic materials, and imaging platforms, with regulatory standards in the United States and Europe guiding safety and efficacy. Innovation trends include integrated navigation and real-time imaging, easier access and drainage solutions, and enhanced biocompatibility of embolic materials. As patient demand for minimally invasive care grows, nonvascular IR devices from Medtronic, Boston Scientific, Terumo, Cook Medical, Merit Medical, AngioDynamics, Stryker, BD, Philips, and Guerbet are positioned to broaden procedural capabilities, expand indications, and improve outcomes in image-guided interventions around the world. Advances will be monitored through independent clinical evaluation.
Key players defining the nonvascular interventional radiology device market include Medtronic (Dublin, Ireland), Boston Scientific (Marlborough, United States), Terumo (Tokyo, Japan), Cook Medical (Bloomington, United States), Merit Medical Systems (South Jordan, United States), AngioDynamics (Latham, United States), Stryker (Kalamazoo, United States), Becton, Dickinson and Company (Franklin Lakes, United States), Philips (Amsterdam, Netherlands), and Guerbet (Villepinte, France). These firms collectively provide nonvascular IR devices such as biopsy needles, ablation technologies, embolic materials, drainage and access tools, as well as image-guidance platforms. Medtronic and Boston Scientific maintain broad portfolios spanning embolization and tumor ablation technologies, while Terumo furnishes extensive microcatheters, guidewires, and coils widely used in percutaneous procedures. Cook Medical and Merit Medical emphasize needle-based and catheter-based systems for biopsy, drainage, and embolization, with Merit’s embolic microspheres representing a benchmark product. AngioDynamics complements this mix with ablation platforms, angiographic accessories, and embolic products; Stryker contributes neurovascular coils, access sheaths, and ancillary IR instruments; BD supplies safety needles and biopsy devices.
Across these firms, core product families span biopsy needles and guidewires, ablation catheters, embolic beads and liquids, drainage and access systems, and advanced imaging platforms for fluoroscopy, CT, and ultrasound guidance. Medtronic's IR portfolio emphasizes embolization and energy-based therapies, supported by globally deployed support networks. Boston Scientific markets a broad line of interventional tools including diagnostic and therapeutic catheters, with a strong presence in percutaneous tumor ablation workflows. Terumo's catalog features microcatheters, hydrophilic guidewires, protective devices, coils used in liver, renal, and pulmonary interventions. Cook Medical and Merit Medical lead in needle and access systems and in embolic materials; Merit's embolic microspheres are widely used in transarterial embolization. AngioDynamics offers ablative platforms and embolic products, while Stryker provides neurovascular and peripheral IR coils and accessories. BD's needle and biopsy devices complement radiology workflows, Philips advances interventional imaging suites and workstations, and Guerbet supplies iodinated contrast agents vital for image-guided procedures.
Overall, the nonvascular IR device market is characterized by diversified portfolios, regional manufacturing hubs, and increasing adoption of image-guided percutaneous therapies. These ten companies maintain global footprints across North America, Europe, and Asia, leveraging partnerships with hospitals, clinics, and research centers to drive clinical adoption and procedural efficiency. Consolidation and strategic collaborations continue to shape product development in needle-based systems, energy-based ablation, embolic materials, and imaging platforms, with regulatory standards in the United States and Europe guiding safety and efficacy. Innovation trends include integrated navigation and real-time imaging, easier access and drainage solutions, and enhanced biocompatibility of embolic materials. As patient demand for minimally invasive care grows, nonvascular IR devices from Medtronic, Boston Scientific, Terumo, Cook Medical, Merit Medical, AngioDynamics, Stryker, BD, Philips, and Guerbet are positioned to broaden procedural capabilities, expand indications, and improve outcomes in image-guided interventions around the world. Advances will be monitored through independent clinical evaluation.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
